1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Netherlands Pharmaceuticals and Healthcare Report Q4 2015

Netherlands Pharmaceuticals and Healthcare Report Q4 2015

  • August 2015
  • -
  • Business Monitor International
  • -
  • 110 pages

Includes 3 FREE quarterly updates

BMI View: The Netherlands has a well-developed healthcare sector and a highly competitive
pharmaceutical industry. With the Dutch economy entering a cyclical growth upswing, we expect higher consumer spending will provide a small boost to pharmaceutical sales in the near term. We forecast the pharmaceutical market will return to growth in 2016, the first time since 2011. Over the long term, medicine demand will be driven by the country's ageing population. However, market potential will continue to be dampened by the patent cliff, rising use of cheaper generic products and further drug price
restrictions.

Headline Expenditure Projections

- Pharmaceuticals: EUR5.92bn (USD7.93bn) in 2014 to EUR5.83bn (USD6.41bn) in 2015; -1.5% in local currency terms and -19.2% in US dollar terms. Forecast in line with last quarter.
- Healthcare: EUR73.31bn (USD98.23bn) in 2014 to EUR74.33bn (USD81.76bn) in 2015; +1.4% in local currency terms and -16.8% in US dollar terms. Forecast revised downwards slightly from last quarter.

Table Of Contents

Netherlands Pharmaceuticals and Healthcare Report Q4 2015
BMI Industry View 7
SWOT 9
Political 11
Economic 12
Operational Risk 13
Industry Forecast 14
Pharmaceutical Market Forecast 14
Table: Pharmaceutical Sales, Historical Data And Forecasts (Netherlands 2011-2019) 16
Healthcare Market Forecast 17
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2011-2019) 20
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2011-2019) 20
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2011-2019) 21
Prescription Drug Market Forecast 22
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Netherlands 2011-2019) 23
Patented Drug Market Forecast 24
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Netherlands 2011-2019) 25
Generic Drug Market Forecast 26
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Netherlands 2011-2019) 27
OTC Medicine Market Forecast 28
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Netherlands 2011-2019) 30
Pharmaceutical Trade Forecast 31
Table: Pharmaceutical Trade Data And Forecasts (Netherlands 2013-2019) 32
Table: Pharmaceutical Trade Data And Forecasts local currency (Netherlands 2013-2019) 32
Key Risks To BMI's Forecast Scenario 33
Macroeconomic Forecasts 35
Economic Analysis 35
Table: GDP Contribution To Growth (Netherlands 2012-2020) 41
Industry Risk Reward Indices 42
Western Europe Risk/Reward Index - Q4 2015 42
Netherlands Risk/Reward Index 47
Rewards 47
Risks 47
Market Overview 49
Industry Trends And Developments 50
Epidemiology 50
Healthcare Sector 52
Table: Healthcare Resources (Netherlands 2009-2014) 54
Table: Healthcare Personnel (Netherlands 2009-2014) 54
Table: Healthcare Activity (Netherlands 2009-2014) 55
Healthcare Funding 55
Health Insurance 55
Table: Key Points Of The Dutch Health Insurance Act, January 1 2006 57
Healthcare Insurance Developments 60
Table: Biosimilars Approved In The EU 60
Research And Development 61
Clinical Trials 62
Biotechnology 64
Regulatory Development 65
Regulatory Developments 66
Intellectual Property Regime 68
Pricing Regime 68
Reimbursement Regime 71
Competitive Landscape 73
Pharmaceutical Industry 73
Table: Pharmaceutical Production, 1995-2010 (EUR '000s) 73
Recent Company Activity 75
Pharmaceutical Wholesale Sector 76
Pharmaceutical Retail Sector 77
Company Profile 80
DSM 80
GlaxoSmithKline 83
Merck and Co 85
Novartis 87
Pfizer 89
Pharming Group 91
Qiagen 94
Sanofi 97
Demographic Forecast 99
Demographic Outlook 99
Table: Population Headline Indicators (Netherlands 1990-2025) 100
Table: Key Population Ratios (Netherlands 1990-2025) 100
Table: Urban/Rural Population and Life Expectancy (Netherlands 1990-2025) 101
Table: Population By Age Group (Netherlands 1990-2025) 101
Table: Population By Age Group % (Netherlands 1990-2025) 102
Glossary 104
Methodology 106
Pharmaceutical Expenditure Forecast Model 106
Healthcare Expenditure Forecast Model 106
Notes On Methodology 107
Risk/Reward Index Methodology 108
Index Overview 109
Table: Pharmaceutical Risk/Reward Index Indicators 109
Indicator Weightings 110

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.